Trial Profile
Evaluation of abatacept versus TNF inhibitors in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 29 Aug 2016 New trial record